Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
56 Cards in this Set
- Front
- Back
chylomicrons are made up of Tg derrived from _______
|
Diet
--intestines-->blood-->periphreal cells |
|
VLDL is made up of Tg from_______
|
Hepatocytes
--Licer-->blood-->periphreal cells |
|
LDL is made up of ________derrived from _________ and is taken _________
|
1) made up of cholesterol
2) it is a VLDL remnant (after Tg is removed) 3) LDL --> Blood --> liver and periphreal cells |
|
HDL does what
|
takes Cholesterol from the periphery to the liver
-- periphreal cells --> blood -->liver |
|
measure serum lipids after how many hours of fasting?
|
10
|
|
term used to describe elevated LDL
|
hypercholesterolemia
|
|
term used to describe elevated chylomicrons or VLDL
|
hypertriglyceridemia
|
|
low HDL puts you at rick for_______
|
heart disease
|
|
list 6 primary lipoprotein disorders
|
1) hypertriglyceridemia (Type IV)
2) chylomicronemia 3) combined hyperlipidemia (type IIb) 4) dysbetalipoprotinemia (TYpe III) 5) hypercholesterolemia (type IIa) 6) ligand defective apolipoprotein B |
|
characteristics of hypertriglyceridemia (Type IV)
|
overproduction of VLDL or low LPL activity
|
|
characteristics of chylomicronemia
|
LPL and cofactor deficiency
|
|
characteristics of combined hyperlipidemia (IIb)
|
increased VLDL production and increased conversion to LDL
|
|
characteristics of Dysbetalipoproteinemia (Type III)
|
Lack of Apo E3,4
|
|
Characteristics of Hypercholesterolemia (IIa)
|
LDL receptor defect
|
|
characteristics of Ligand defective apolipoprotein B
|
defect in ligand domain of apoB100
|
|
secondary causes of lipoprotein disorders
|
1) drug induced
--diuretics --BB --isotretinoin --OCP 2) Other diseases --diabetes --hypothyroidism --alcoholism --renal disease --Liver disease |
|
describe the therapudic lifestyle change to treat lipoprotein disorders
|
1) therapudic diet
--total fat 20-25% of total callories --saturated fat <7% of callories --cholesterol <200mg/day --soluble fiber 2) weight reduction 3) physical activity |
|
drugs used to tx hyperlipidemia
|
1) statins
2) niacin 3) bile acid binding resins 4) fibrates |
|
list 6 statins
|
1) lovastatin
2) simvastatin 3) pravastatin 4) atorvastatin 5) fluvastatin 6) rosuvastatin |
|
what is the MOA for all statins
|
inhibits HMG-CoA reductase -->
decrease hepati Cholesterol synthesis--> upregulate hepatic LDL receptors--> increase uptake of LDL cholesterol--> decrease serum and total cholesterol |
|
which of the statins are inactive lactone prodrugs?
|
1) Lovastatin
2) Simvastatin |
|
which of the statins has an open, active lactone ring?
|
pravastatin
|
|
which of the statins is active, and fluorine containing
|
1) atorvastatin
2) fluvastatin 3) rosuvastatin |
|
most statins have short half lifes (2-3 hours) so when must they be given?
|
1) administered in evening so peak effect occurs during nocturnal peak of cholesterol synthesis
|
|
which statin has absorption increased when taken with food?
|
lovostatin
|
|
which statins have a long half life?
|
atorvastatin (11-14 hours)
Rosuvastatin --therefore can be administered antime...not just the evening |
|
most statins are metabolized by________
|
CYP 3A
|
|
which statin is not metabolized by CYP 3A?
|
pravastatin
--therefore fewer drug interactions |
|
common CYP 3A inhibitors
|
1) erythromycin
2) azole antifungal drugs (ketoconazole) 3) antidepressants 4) HIV protease inhibitors |
|
adverse effects of statins
|
1) liver toxicity
2) muscle myositis (inflamed muscle) 3) muscle myalgia (muscle pain) |
|
name the bile acid binding resins
|
1) colestipol
2) cholestyramine 3) cikesevelam |
|
MOA of the bile acid binding resins
|
1) bind to the bile acid in the GI tract
2) prevents reabsorption of the bile acid 3) increases utilization of cholesterol to replace bile acids |
|
clinical use of bile acid binding resins
|
1) persons not tollerating other drugs fr hypercholesterolemia
2) additive effect with other drugs |
|
pharmicokinetics of bile acid binding resins
|
1) administered before meals and at bedtime
2) not absorbed from the gut |
|
drug interaction of bile acid binding resins
|
1) inhibits absorption of:
--digoxin --thyroid hormone --other ****cholestyramine is the only one of the bile acid binding resins that can be used with any other drug |
|
adverse effects of the bile acid binding resins
|
1) may cause constipation
|
|
which drug inhibits intestinal sterol absorption?
|
Ezetimibe
|
|
MOA of Ezetimibe
|
1) Ezetimibe localizes in the brush border of the small intestine
2) it inhibits the absorption of cholesterol |
|
effects of Ezetimibe on lipids
|
1) decrease LDL
2) Decrease TG 3) Increase HDL |
|
pharmicokinetics of Ezetimibe
|
1) absorbed in the small intestine
2) t1/2 = 22h 3) metabolized by conjugation w/ glucournate 4) 80% excreted in feces |
|
adverse effect of Ezetimibe
|
few...none mentioned
|
|
unique characteristic of Ezetimibe
|
1) can be used alone or combined with a statin
--i.e. Vytorin = Ezetimibe +simvastatin |
|
name the fibric acid drugs
|
1) Gemfibrozil
2) Fenofibrate |
|
MOA of the fibrates (fibric acid drug)
|
1) PPAR - alpha ligand
--Bind PPAR - alpha RE (promotor region of the gene) --> transcription induction --> LPL (HDL apolipoprotein) |
|
effect of fibrates on the lipids
|
1) increase FA catabolism
2) decrease VLDL secretion 3) increase VLDL clearance 4) decrease TG levels |
|
clinical use of fibrates
|
1) tx hypertriglyceridemia
2) tx low HDL levels??? |
|
adverse effect of fibrates
|
1) myopathy, rhabdomyolysis
2) bone marrow supression 3) exfoliative dermatitis |
|
niacin is what type of acid?
|
nicotinic acid
|
|
MOA of niacin
|
simular to fibrates except greater effect on LDL
--inhibit VLDL secretion --Activate LPL (directly) |
|
effects of Niacin on the lipids
|
1) lower LDL
2) lower TG 3) Increase HDL (more than any oter drug alone) |
|
clinical use of niacin
|
1) hypercholesterolemia
2) hypertriglyceridemia 3) Low HDL |
|
adverse effects of niacin
|
1) cutaneous flushing
2) hepatitis 3) increase in blood glucose (be careful in diabetics) 4) aggrevate in peptic ulcers 5) myopathy, rhabdomyolysis |
|
avoid the use of gemfibrozil with the use of__________
|
niacin
|
|
use statins cautiously when patient is on__________or _______
|
gemfibrozil or niacin
|
|
drugs used to tx hypercholesterolemia
|
1) HMG-CoA reductase inhibitors - ‘statins’
2) Bile acid-binding resins 3) Niacin 4) Ezetimibe |
|
Drugs for hypertriglyceridemia and low HDL
|
1) Gemfibrozil
2) Niacin |